Clinical impacts of hazardous alcohol use and obesity on the outcome of entecavir therapy in treatment-naïve patients with chronic hepatitis B infection.

Clinical and molecular hepatology

Volumn 18, Issue 2, 2012, Pages 195-202

  Chung, Won Gil ^a   Kim, Hong Joo ^b   Choe, Young Gil ^b   Seok, Hyo Sun ^b   Chon, Chang Wook ^b   Cho, Yong Kyun ^b   Kim, Byung Ik ^b   Koh, Young Yool ^b  

^a School of Medicine   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; DRUG DERIVATIVE; ENTECAVIR; GUANINE; VIRUS DNA;

ADULT; ARTICLE; BLOOD; BODY MASS; COHORT ANALYSIS; DRINKING BEHAVIOR; FEMALE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; ALANINE TRANSAMINASE; ALCOHOL DRINKING; ANTIVIRAL AGENTS; BODY MASS INDEX; COHORT STUDIES; DNA, VIRAL; FEMALE; GUANINE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84871856422     PISSN: None     EISSN: 2287285X     Source Type: Journal    
DOI: 10.3350/cmh.2012.18.2.195     Document Type: Article

References (0)